Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ISRCTN20052152 | Registry Identifier | International Standard Randomised Controlled Trial Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There are times in life when people cannot use their muscles, such as during illness or injury. Muscle and mitochondria (the 'energy factory' in cells) health decline very quickly when people cannot use their muscles, but certain foods can help reduce these declines. Recent research suggests that Urolithin A, which is a natural compound that can be produced after eating pomegranates, nuts, and berries, improves muscle health. In this study, the investigators aim to investigate if a protein beverage (standard care during disuse) with or without Urolithin A can reduce or prevent the loss of muscle health while wearing a knee brace (muscle disuse).
After participants provide informed consent to participate and are deemed eligible for the study (Day 0), participants will sequentially complete the three phases of this study:
Participants will consume their randomly assigned supplement daily during all three phases.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Protein supplement | Active Comparator |
| |
| Protein supplement with Urolithin A | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Protein supplement | Dietary Supplement | Ready-to-drink protein beverage consumed once daily for 28 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in maximal mitochondrial respiration (rate of oxygen flux) and mitochondrial ADP [adenosine diphosphate] sensitivity (Oroboros O2k) | Oxygen flux in muscle measured using Oroboros | Outcome measured and reported for: Day 7, Day 14, Day 28, Day 35 |
| Measure | Description | Time Frame |
|---|---|---|
| Muscle strength (Biodex) | Isometric leg extension strength | Day 7, Day 14, Day 28, Day 35 |
| Quadriceps muscle size | Muscle size measured using MRI |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stuart Phillips | McMaster University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| McMaster University | Hamilton | Ontario | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020966 | Muscular Disorders, Atrophic |
| ID | Term |
|---|---|
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C026423 | 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Protein supplement with Urolithin A | Dietary Supplement | Ready-to-drink protein beverage with 1000 mg of Urolithin A consumed once daily for 28 days |
|
| Outcome measured and reported for: Day 14, Day 28, Day 35 |
| Muscle protein fractional synthetic rate | Protein synthetic rate using labelled alanine incorporation | Day 7, Day 14, Day 28, Day 35; integrated synthesis rates reported for Day 7-14, Day 14-28; Day 28-35 |